Wall Street analysts expect FibroGen, Inc. (NASDAQ:FGEN) to post sales of $78.59 million for the current fiscal quarter, Zacks reports. Six analysts have provided estimates for FibroGen’s earnings, with the lowest sales estimate coming in at $39.10 million and the highest estimate coming in at $200.00 million. FibroGen reported sales of $42.89 million during the […]
